Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson’s Disease

Figure 11

Treatments with CS25 or EGCG10 of 6-OHDA-lesioned animals reversed at least partially the increased immunostainings for iNOS, mainly in CA1, CA3 areas, but also in DG hippocampal subfields. The data were quantified by the Image J software. CA1: a: versus SO, ; b: versus 6-OHDA + CS25, ; c: versus 6-OHDA + EGCG10, . CA3: a: versus SO, ; b: versus 6-OHDA + CS25, ; c: versus 6-OHDA + EGCG10, . DG: a: versus SO, ; b: versus 6-OHDA + CS25, ; c: versus 6-OHDA + EGCG10, ; d: versus SO, ; e: versus SO, (one-way ANOVA and Newman-Keuls as the post hoc test).

(a)

(b)

(c)